Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Drug Screening market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Drug Screening market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Drug Screening market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Drug Screening products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Drug Screening products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Drug Screening market.
To learn more about this report
Increasing research and development spending on Drug Screening development has been the leading industry trend of Drug Screening market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents |
| By Application Outlook | Hospitals, Research Institute, Pharmaceuticals & Healthcare & Pharmaceutical Companies, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Drug Screening Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Drug Screening Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Drug Screening Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Drug Screening Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Immunoassay Analyzers
4.2.2 Chromatography
4.2.3 Breath Analyzers
4.2.4 Rapid Testing Devices
4.2.5 Assay Kits and Reagents
4.4 Type Comparison Matrix
4.5 Global Drug Screening Market Attractiveness, By Type
5 Global Drug Screening Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Drug Screening Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Hospitals
5.3.2 Research Institute
5.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
5.3.4 Others
5.4 Application Comparison Matrix
5.5 Global Drug Screening Market Attractiveness, by Application
6 Global Drug Screening Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Drug Screening Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Drug Screening Market Attractiveness, by Region
8 North America Drug Screening Market Analysis and Forecast
8.1 Key Findings
8.2 North America Drug Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Immunoassay Analyzers
8.2.2 Chromatography
8.2.3 Breath Analyzers
8.2.4 Rapid Testing Devices
8.2.5 Assay Kits and Reagents
8.3 North America Drug Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Hospitals
8.3.2 Research Institute
8.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
8.3.4 Others
8.4 North America Drug Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Drug Screening Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Drug Screening Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Drug Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Immunoassay Analyzers
9.2.2 Chromatography
9.2.3 Breath Analyzers
9.2.4 Rapid Testing Devices
9.2.5 Assay Kits and Reagents
9.3 Europe Drug Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Hospitals
9.3.2 Research Institute
9.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
9.3.4 Others
9.4 Europe Drug Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Drug Screening Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Drug Screening Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Drug Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Immunoassay Analyzers
10.2.2 Chromatography
10.2.3 Breath Analyzers
10.2.4 Rapid Testing Devices
10.2.5 Assay Kits and Reagents
10.3 Asia Pacific Drug Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Hospitals
10.3.2 Research Institute
10.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
10.3.4 Others
10.4 Asia Pacific Drug Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Drug Screening Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Drug Screening Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Drug Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Immunoassay Analyzers
11.2.2 Chromatography
11.2.3 Breath Analyzers
11.2.4 Rapid Testing Devices
11.2.5 Assay Kits and Reagents
11.3 Latin America Drug Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Hospitals
11.3.2 Research Institute
11.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
11.3.4 Others
11.4 Latin America Drug Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Drug Screening Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Drug Screening Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Drug Screening Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Immunoassay Analyzers
12.2.2 Chromatography
12.2.3 Breath Analyzers
12.2.4 Rapid Testing Devices
12.2.5 Assay Kits and Reagents
12.3 Middle East & Africa (MEA) Drug Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Hospitals
12.3.2 Research Institute
12.3.3 Pharmaceuticals & Healthcare & Pharmaceutical Companies
12.3.4 Others
12.4 Middle East & Africa (MEA) Drug Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Drug Screening Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Abbott
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Express Diagnostics
13.3.3 Laboratory Corporation of America
13.3.4 MPD
13.3.5 Quest Diagnostics
13.3.6 Roche Diagnostics
13.3.7 Shimadzu
13.3.8 Siemens Healthcare
13.3.9 Thermo Fisher Scientific
14 Key Takeaways
Choose License Type